Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Regeneron Pharmaceuticals Inc.

(REGN)

Robert Faulkner of S.G. Warburg raised REGN to "hold" from "reduce" following the Tarrytown, N.Y.,

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE